- Health Canada Approves Otsuka and Lundbeck’s ABILIFY MAINTENA® (aripiprazole for prolonged release injectable suspension) Alternative Initiation Regimen - March 3, 2021
- 'Montréal's Top Employers' for 2021 Announced - February 9, 2021
- Health Canada approves Lundbeck’s PrVYEPTI® (eptinezumab)—the first and only intravenous preventive treatment for migraine - January 12, 2021
You are now leaving the Lundbeck Canada website
Links to sites outside of Lundbeck Canada are provided as resources to visitors and may not reflect Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility for the content of linked sites.
Lundbeck Canada News Archive
Releases - all the latest on Lundbeck
Keep updated on our latest corporate releases, press releases and features.